Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas

被引:44
作者
Andersson, S.
Wallin, K-L
Hellstroem, A-C
Morrison, L. E.
Hjerpe, A.
Auer, G.
Ried, T.
Larsson, C.
Heselmeyer-Haddad, K.
机构
[1] Karolinska Univ Hosp Solna, Karolinska Inst, Dept Mol Med & Surg, SE-17176 Stockholm, Sweden
[2] Karolinska Inst, Karolinska Hosp, Dept Clin Sci Intervent & Technol, Div Obstet & Gynecol, SE-14186 Stockholm, Sweden
[3] Karolinska Inst, Karolinska Univ Hosp, Radiumhemmet, Dept Gynecol Oncol, SE-17176 Stockholm, Sweden
[4] Abbott Mol, Des Plaines, IL 60018 USA
[5] Karolinska Inst, Karolinska Univ Hosp Solna, Dept Oncol Pathol, CCK, SE-17176 Stockholm, Sweden
[6] NCI, Genet Branch, Canc Res Ctr, NIH, Bethesda, MD 20892 USA
关键词
cervical adenocarcinoma; human papillomavirus; interphase fluorescence in situ hybridisation; chromosome arm 3q; telomerase; early detection;
D O I
10.1038/sj.bjc.6603253
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The level of genomic amplification of the human telomerase gene TERC, which maps to chromosome band 3q26, was determined in primary cervical adenocarcinomas. Interphase nuclei prepared from archival material of 12 primary cervical adenocarcinomas, eight of which were human papillomavirus positive, were hybridised with a triple colour probe set specific for centromeres of chromosomes 3 and 7 and the TERC gene. We observed high proportions of nuclei with increased absolute copy numbers for TERC in all tumours (mean 3.3; range 2.3-5.2). Amplification of the human telomerase gene TERC is a consistent aberration in cervical adenocarcinomas. Therefore, application of our probe set may provide an objective genetic test for the assessment of glandular cells in Pap smears and hence for the diagnosis of cervical adenocarcinomas.
引用
收藏
页码:331 / 338
页数:8
相关论文
共 41 条
[1]   Adenocarcinoma of the uterine cervix:: the presence of human papillomavirus and the method of detection [J].
Andersson, S ;
Larson, B ;
Hjerpe, A ;
Silfverswärd, C ;
Sällström, J ;
Wilander, E ;
Rylander, E .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2003, 82 (10) :960-965
[2]  
Andersson S, 2003, ONCOL REP, V10, P175
[3]  
Benedet JL, 2000, INT J GYNECOL OBSTET, V70, P209
[4]   Trends in cancer of the cervix uteri in Sweden following cytological screening [J].
Bergström, R ;
Sparén, P ;
Adami, HO .
BRITISH JOURNAL OF CANCER, 1999, 81 (01) :159-166
[5]  
BITTNER ML, 1996, Patent No. 5491224
[6]   PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE [J].
BOSCH, FX ;
MANOS, MM ;
MUNOZ, N ;
SHERMAN, M ;
JANSEN, AM ;
PETO, J ;
SCHIFFMAN, MH ;
MORENO, V ;
KURMAN, R ;
SHAH, KV ;
ALIHONOU, E ;
BAYO, S ;
MOKHTAR, HC ;
CHICAREON, S ;
DAUDT, A ;
DELOSRIOS, E ;
GHADIRIAN, P ;
KITINYA, JN ;
KOULIBALY, M ;
NGELANGEL, C ;
TINTORE, LMP ;
RIOSDALENZ, JL ;
SARJADI ;
SCHNEIDER, A ;
TAFUR, L ;
TEYSSIE, AR ;
ROLON, PA ;
TORROELLA, M ;
TAPIA, AV ;
WABINGA, HR ;
ZATONSKI, W ;
SYLLA, B ;
VIZCAINO, P ;
MAGNIN, D ;
KALDOR, J ;
GREER, C ;
WHEELER, C .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11) :796-802
[7]   The viral etiology of cervical cancer [J].
Bosch, FX ;
Muñoz, N .
VIRUS RESEARCH, 2002, 89 (02) :183-190
[8]   Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors:: Implications for screening and prevention [J].
Castellsagué, X ;
Díaz, M ;
de Sanjosé, S ;
Muñoz, N ;
Herrero, R ;
Franceschi, S ;
Peeling, RW ;
Ashley, R ;
Smith, JS ;
Snijders, PJF ;
Meijer, CJLM ;
Bosch, FX .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (05) :303-315
[9]   PREPARATION OF CELL-NUCLEI FROM FRESH TISSUES FOR HIGH-QUALITY DNA FLOW-CYTOMETRY [J].
CASTRO, J ;
HEIDEN, T ;
WANG, NN ;
TRIBUKAIT, B .
CYTOMETRY, 1993, 14 (07) :793-804
[10]   Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis [J].
Clifford, GM ;
Smith, JS ;
Aguado, T ;
Franceschi, S .
BRITISH JOURNAL OF CANCER, 2003, 89 (01) :101-105